Position in FBRX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$30,770,754
-$8,110,402 QoQ
Shares Held
1,188,060
-16.7% QoQ
Ownership
5.60%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in FBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $15,213,180,190 across 182 Biotechnology names. FBRX ranks #62 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,541,732 | $1,856,099,791 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
3,458,863 | $1,114,411,067 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,018,647 | $1,056,701,142 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
13,179,013 | $978,673,503 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
16,575,875 | $963,224,094 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,131,527 | $951,812,064 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
9,766,496 | $949,791,733 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
6,945,813 | $641,654,204 |
All Filings in FBRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-07-31 | $39,909,825 | 521,016 | Shares | Sole | 2026-08-07 | |
| 2026-06-30 | $40,249,115 | 1,894,076 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $30,770,754 | 1,188,060 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $38,881,156 | 1,425,785 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $21,057,630 | 1,403,842 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $18,035,436 | 1,394,852 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,139,200 | 920,000 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||